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The 15-kDa selenoprotein (Sep15) is a thioredoxin-like,
endoplasmic reticulum-resident protein involved in the quality
control of glycoprotein folding through its interaction with
UDP-glucose:glycoprotein glucosyltransferase. Expression of
Sep15 is regulated by dietary selenium and the unfolded protein
response, but its specific function is not known. In this study, we
developed and characterized Sep15 KO mice by targeted
removal of exon 2 of the Sep15 gene coding for the cysteine-
rich UDP-glucose:glycoprotein glucosyltransferase-binding
domain. These KO mice synthesized a mutant mRNA, but the
shortened protein product could be detected neither in tissues
nor in Sep15 KO embryonic fibroblasts. Sep15 KO mice were
viable and fertile, showednormal brainmorphology, anddidnot
activate endoplasmic reticulum stress pathways. However,
parameters of oxidative stresswere elevated in the livers of these
mice. We found that Sep15 mRNA was enriched during lens
development. Further phenotypic characterization of Sep15KO
mice revealed a prominent nuclear cataract that developed at an
early age. These cataracts did not appear to be associated with
severe oxidative stress or glucose dysregulation.We suggest that
the cataracts resulted from an improper folding status of lens
proteins caused by Sep15 deficiency.
Selenium (Se) is a trace element that plays a role in immune
function, reducing cancer incidence, and redox homeostasis in
mammals (1–3). Se is primarily used in the form of selenocys-
teine, known as the 21st amino acid, which is encoded by UGA
codon and located in the active sites of oxidoreductases (4, 5).
The 15-kDa selenoprotein (Sep15) was identified in mam-
mals 13 years ago as a protein of unknown function (6). The
NMR structure of theDrosophila melanogaster Sep15 revealed
a thioredoxin-like fold within its oxidoreductase domain, with
selenocysteine (Sec)2 located in the predicted catalytic position
(7). Previous studies showed that Sep15 resides in the endoplas-
mic reticulum (ER) and interacts with UDP-glucose:glycopro-
tein glucosyltransferase (UGT) (8). The latter protein is a part of
the calnexin-calreticulin glycoprotein folding cycle and is
known to be responsible for targeting unfolded glycopro-
teins for calcium-dependent transient glucosylation. Sep15
contains the ER targeting peptide, but lacks an ER retention
signal. The tight binding to UGT allows retention of Sep15 in
the ER. These findings suggested that Sep15 may assist UGT
function and control folding or secretion of certain
glycoproteins.
Recently, Sep15 was found to be regulated by ER stress.
Sep15 expression was up-regulated in response to adaptive ER
stress caused by tunicamycin and brefeldinA.At the same time,
more robust ER stress caused by DTT and thapsigargin treat-
ments induced rapid proteasomal degradation of Sep15 (9).
Presumably, disruption of Sep15-UGT interaction because of
reduction of disulfide bonds in the Sep15UGT-binding domain
displaced Sep15 from the ER. Expression of Sep15 is higher in
tissues with secretory functions, such as liver, kidney, prostate,
and thyroid (10). Comparison of expression of Sep15 and other
components of the protein folding quality control machinery
revealed similar expression patterns in mouse brain, including
enriched levels in the hippocampus and cerebellum. This
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observation further pointed to the role of Sep15 in glycoprotein
folding (9).
Several studies suggested a role of Sep15 in cancer preven-
tion. First, the human Sep15 gene is located on chromosome
1p31, in the locus often deleted or mutated in human cancers.
In addition, Sep15 has two polymorphic sites that differentially
regulate expression of this protein in response to selenium sup-
plementation (11).Moreover, levels of Sep15 were decreased in
prostate cancer cell lines and in hepatocarcinoma compared
with non-transformed cells and tissues. Sep15 expression is
also lowered in malignant lung, breast, prostate, and liver (12).
These observations suggest a role of Sep15 in tumor suppres-
sion, possibly through regulation of folding and/or secretion of
cancer-related glycoprotein substrates. However, the specific
function of Sep15 in this process is not understood. At the same
time, recent research demonstrated an opposite role for Sep15
in the promotion of growth of colon cancer cells (13, 14). Stable
knockdownof Sep15 significantly reduced growth ofCT26 cells
in culture and prevented formation of colonies on soft agar.
Mice injected with the Sep15-deficient cells developed fewer
tumors and did not form pulmonary metastases as did mice
injected with control cells. However, Sep15 deficiency had no
effect on the growth of lung cells.
In this study, we describe Sep15 KO mice lacking exon 2 of
the gene. Although the mutant mRNAwas detected, the short-
ened dysfunctional Sep15 form was not present in these mice.
Analyses of Sep15 KOmice did not reveal signs of ER stress and
gross abnormalities. However, livers of Sep15 KOmice showed
increased levels of malondialdehyde and protein carbonyls,
indicative of mild oxidative stress. During the course of further
analyses, we found that Sep15mRNAwas enriched in the devel-
oping ocular lens. Consistent with this observation, deficiency
in the protein because of Sep15KO resulted in the development
of cataracts. This study highlights the roles of Sep15 in redox
homeostasis and glycoprotein folding and indicates its function
in the maintenance of lens transparency.
EXPERIMENTAL PROCEDURES
Development of Sep15 KO Mice—The Sep15 KO construct
was prepared as follows. A 4202-bp fragment of Intron 1 was
amplified from 129/Sv mouse genomic DNA by nested PCR
with the following primers: round 1, 5-CCAGTTAACTTCT-
ACGGGTCTGTTACAAGTGGT-3 and 5-GTCCAGGCTG-
GCCCTGAACTAGCTCTGTGC-3; and round 2, 5-GTGG-
TCTCGAGTGGAAGCATCATTGACAGTTGATGGTACT-
GAAGTG-3 and 5-CTGTGCTCGAGACGACCTCACCCT-
GATTCTCCTGTCCAGTTCAGG-3. The amplified frag-
ment was cloned into the XhoI site of the pPNT vector. A sec-
ond fragment of 4246 bp of intron 2 was amplified from 129/Sv
mouse genomic DNA by nested PCR with the following prim-
ers: round 1, 5-GCATACCAGGATTCATTCCACTGAGGC-
TGTCC-3 and 5-ACCCATCTTTATGGACGGTGTCACA-
TGTC-3; and round 2, 5-AGGACCGGATCCCAGGATCA-
CCATTGCCCTAGGCTTCCTGG-3 and 5-CCTGTGGA-
TCCTGACTCTGCTGGCTGTGGTGGTTGTAGAGAAGC-
3. The amplified fragment was cloned into the BamHI site of
the pPNT vector. The correct insert orientation of the frag-
ments was confirmed by restriction analysis. The construct was
digested with NotI, DNA fragments were separated by agarose
gel electrophoresis, and the targeting DNA was purified from
the gel. 129/Sv embryonic stem cells were transfected with the
targeting construct, and recombinants were selected by grow-
ing stem cells in a neomycin-containing medium. Clones with
successful construct recombination were identified by nested
PCR with the following primer pairs for the neo-cassette and
genomicDNA thatwas not part of the targeting construct: frag-
ment 1, round 1, 5-GGGAAGACAGTACCTTGTCATGTA-
AGTGG-3 and 5-GCTGCTAAAGCGCATGCTCCA-
GACTGCCTTGG-3; fragment 1, round 2, 5-CCAG-
TTAACTTCTACGGGTCTGTTACAAGTGG-3 and 5-
CCTACCCGGTAGAATTGACCTGCAGG-3; fragment 2,
round 1, 5-GAACGAGATCAGCAGCCTCTGTTCCAC-3
and 5-ACCCATCTTTATGGACGGTGTCACATGTC-3;
and fragment 2, round 2, 5-GTTCTAATTCCATCAGAA-
GCTGACTCTAGA-3 and 5-CAGTCATGTTGCGC-
TGCCTTCCTGCCT-3. Cells with proper construct inte-
gration were microinjected into C57Bl/6 blastocysts. The
resulting chimeric mice were then mated with C57Bl/6 mice.
Germ line transmission was confirmed by nested PCR as
described above. The KO allele was transferred to the
C57Bl/6 background through five rounds of cross-breeding
with C57Bl/6mice, and homozygous Sep15 KO animals were
then generated by cross-breeding of Sep15 KO heterozygous
mice. The KO phenotype was confirmed by Southern blot-
ting, 75Se metabolic labeling, and immunoblot analyses as
described under “Results.” For the RT-PCR experiments,
total liver RNA was isolated by TRIzol extraction according
to the manufacturer’s protocol (Invitrogen). Genomic DNA
was removed using a DNA removal kit (Ambion, Inc.). RNA
was quantified with a spectrophotometer, and 5 g were
transcribed with 50 ng of random primer and 200 units of
SuperScript III reverse transcriptase (Invitrogen). 1 l of the
resulting cDNA was used for analysis with primers specific
for various regions of the mouse Sep15 gene.
Isolation of Mouse Embryonic Fibroblasts (MEFs) and Meta-
bolic Labeling with 75Se—Embryos generated from WT and
Sep15 KO mice were dissected out at embryonic day 13.5 and
separated from maternal tissues. The embryos were treated
with 0.05% trypsin at 4 °C for 30 min and incubated at 37 °C for
1 h. Embryonic cells were cultured in DMEM supplemented
with 20% fetal bovine serum, 2 mM glutamine, 50 M -mer-
captoethanol, and 100 units/ml penicillin/streptomycin. After
4 weeks, an aliquot of cells was frozen, and another aliquot was
used for further experiments. For the analysis of Sep15 expres-
sion, WT and Sep15 KO MEFs were grown in DMEM supple-
mented with freshly neutralized 75Se-selenious acid (specific
activity 1000 Ci/mmol, final concentration in the medium,
1 nM) for 24 h. Sep15 was immunoprecipitated using a protein
G immunoprecipitation kit (Sigma) and 5 l of Sep15-specific
antibodies. Selenoproteins were visualized by SDS-PAGE fol-
lowed by autoradiography using a PhosphorImager.
Cloning and in Vitro Expression of the Sep15 and Sep152
Forms—To analyze the possibility of expression of the Sep15
form lacking the Cys-rich UGT-binding domain encoded by
exon 2 (Sep152), the Sep152 nucleotide sequence was ampli-
fied from Sep15 KO cDNA (prepared from total liver RNA)
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with primers 5-ATCACTCGAGATGGCGGCAGGGC-
AGG-3 and 5-TGACTCTAGATTAATGATGATGATGAT-
GATGTATGCGTTCCAACTTCTCG-3 containing the XhoI
andXbaI restriction sites and subcloned into pCI-neo using the
corresponding restriction enzymes. The SECIS (Sec Insertion
Sequence) element was separately amplified with the 5-TGA-
CTCTAGATTAGTAGTTTTTATACTAATC-3 and 5-
ATGACGATCTGCGGCCGCTTTTTTTTAAAATCAAAC-
ATATTTGAAAG-3 primers and cloned into the resulting
vector at the Xba1 andNot1 sites. For localization experiments,
the full-length Sep15 and Sep152 sequences were cloned into
the pEGFPN1 vector with primers 5-ATCAGCTAGCATGG-
CGGCAGGGCAGG-3 and 5-ACTTACAATATTACCGGT-
ATTATGCGTTCCAACTTCTCG-3 containing theNheI and
AgeI restriction sites. All constructs were verified by sequenc-
ing. Sec was substituted with Cys by site-directed mutagenesis
with primers 5-CTTGAAGTCTGCGGATGTAAATTGGG-
GAGGTTCC-3 and 5-GGAACCTCCCCAATTTACATC-
CGCAGACTTCAAG-3 (the introduced mutations are
underlined).
Cell Culture Studies—HumanHEK293 cells,mouseNIH3T3
cells, and MEFs were cultured in DMEM supplemented with
10% FBS, 100 units/ml penicillin, and 100 units/ml streptomy-
cin. Transfections were carried out using Lipofectamine (Invit-
rogen) according to the manufacturer’s instructions. To ana-
lyze expression of Sep15 and Sep152, HEK293 cells were
transfected with the pCI-neo vector coding for full-length
Sep15 and Sep152 forms, and 18 h after transfection, the
medium was replaced with that containing freshly neutralized
75Se-selenious acid (specific activity, 1000 Ci/mmol; final con-
centration in the medium, 1 nM). Cells were metabolically
labeled for 24 h, and expression of selenoproteins was analyzed
by SDS-PAGE followed by autoradiography.
To further analyze the expression of the full-length and
Sep152 forms, NIH 3T3 cells were grown in 6-well plates and
transfected with the corresponding EGFP fusion constructs or
with an empty vector. Twenty-four hours after transfection, the
original medium was replaced with serum-free medium, and
after an additional 24 h, cells and media were collected. Cell
lysates were prepared using CellLytic buffer (Sigma) according
to the manufacturer’s instructions. The conditioned media
were concentrated to 40 l using Centricon concentrators
(Millipore). Cell extracts and concentratedmedia samples were
analyzed by Western blotting using GFP-specific antibodies
(Sigma).
To further characterize the expression of the full-length and
Sep152 forms, NIH 3T3 cells were grown on coverslips, trans-
fected with the corresponding constructs in pEGFPN1 expres-
sion vector, and 24 h after transfection, treated with 1 M ER-
Tracker Blue-White DPX dye (Invitrogen) for 20 min. Then,
cells were washed with PBS, fixed in 4% formaldehyde in PBS,
andmounted withmountmedia. Images were collected using a
Bio-Rad MRC1024ES laser scanning microscope.
Metabolic Labeling of WT and Sep15 KO Mice—WT,
heterozygous, and homozygous Sep15 KO mice received an
intraperitoneal injection of 40 Ci of freshly neutralized 75 Se-
selenious acid and were maintained on a 12-h light/dark cycle
and a regular diet. After 48 h, mice were sacrificed, and extracts
were prepared from various tissues in ice-cold PBS (pH 7.6)
supplemented with complete protease inhibitor mixture
(Roche). Extracts from the indicated tissues were subjected to
SDS-PAGE, and proteins were transferred onto polyvinylidene
difluoride membranes and analyzed with a PhosphorImager.
Tissue and Blood Preparation—Blood was obtained from
sacrificed Sep15 KO and control mice from the heart vein.
Brain and prostate tissues were immediately fixed in 10% neu-
tral buffered formalin and washed with PBS. PBS-washed tis-
sues were embedded in paraffin and cut on a standard
microtome to 5-m sections. The sections were deparaffinized
in xylene and stained with hematoxylin (Invitrogen) and eosin
(Sigma) to reveal the fine tissue structure. Images were taken
using a light Olympus AX70 microscope. For prostate-specific
antigen (PSA) analysis, erythrocytes were removed by centrif-
ugation, and 30g of serumproteinswere analyzed byWestern
blotting with PSA-specific antibodies (Dako). Brains were
stained with the indicated antibodies at dilutions of 1:1000–1:
5000 at 4 °C overnight.
Analyses of Oxidative Stress Parameters—Protein extracts
from liver, kidney, heart, testis, and brain were prepared in PBS
containing a complete protease inhibitor mixture. Malondial-
dehyde was measured using the Oxiselect Thiobarbituric Acid
Reactive Substances (TBARS) assay kit (Cell Biolabs, SanDiego,
CA) according to the manufacturer’s instructions. Protein car-
bonyl content was assayed using 2,4-dinitrophenyl hydrazine
(molar extinction coefficient of 22mm1 cm1). Total and pro-
tein thiol contents were measured using 5,5-dithiobis(2-nitro-
benzoic acid).
Analysis of SelP Secretion in Hepatocytes—Hepatocytes of
WT and Sep15 KOmice were obtained according to the proce-
dures published previously (15, 16). Briefly, livers from
3-month-old mice were perfused with Ca2- and SO42-free
buffer (6 mM glucose, 115 mM NaCl, 25 mM NaHCO3, 6 mM
KCl, 1 mM MgCl2x6H2O, 1 mM NaH2PO4). After liver was
cleared from the blood, collagenase (700 units/ml, Sigma) was
added at the concentration of 0.1mg/ml. Tissueswere removed
and dissociated by gentle rubbing in perfusion buffer. The sus-
pensionwas then filtered through a 70-mcell strainer by grav-
ity flow. Then, hepatocytes were washed three times in Wil-
liams E medium (Sigma) supplemented with 2 mM L-glutamine
(Invitrogen) seeded on collagen-coated 5-cm plates. Forty-
eight hours later, themediumwas replaced with 3ml of serum-
free medium containing freshly neutralized 75Se selenious acid
and supplemented with dimethyl sulfoxide or ER stress-induc-
ing agents, 1 mM DTT, 10 g/ml brefeldin A, 5 g/ml tunica-
mycin, or 20Mmonensin. Cells andmedia were collected 24 h
later, andmedia samples were concentrated as described above
for NIH 3T3 cells. Cell lysates and concentrated media were
analyzed by SDS-PAGE followed by autoradiography.
Tunicamycin Injection—WT and Sep15 KOmice were given
a single 1 g/g body weight intraperitoneal injection of a 0.05
mg/ml suspension of tunicamycin in 150 mM dextrose as
described (17). Thesemicewere euthanized 72 h after injection,
and their livers were removed. Protein lysates were resolved by
SDS-PAGE and analyzed byWestern blotting using antibodies
specific for Sep15, BiP, and -actin.
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Analysis of Sep15 Expression in the Lens During Embryonic
Development—Mouse embryonic head tissues were fixed in 4%
p-formaldehyde solution for 30 min on ice, equilibrated with
30% sucrose overnight at 4 °C, and embedded in OCT for cryo-
sectioning. Coronal sections at 13-m thickness were gener-
ated using a cryostat (Leica). Frozen sections of embryos at
various stages of development were brought to room tempera-
ture (RT), blocked for 15 min at RT with a blocking solution
containing 5% chicken serum and 0.01% Tween in PBS, and
incubated at 4 °C overnight with a rabbit anti-mouse Sep15
antibody at 1:50 dilution in blocking buffer. After three 5-min
washes with PBS, sections were incubated for 1 h at room tem-
perature with chicken anti-rabbit Alexa Fluor 595 secondary
antibodies (Invitrogen). Sections were stained with DAPI for 5
min followed by washing, mounting, and image collection. All
experiments were performed with primary and secondary anti-
body-only controls that exhibited no detectable signal, and
images were obtained by confocal microscopy using a Leica
model TCS SP2 instrument with optical sections of 0.6–1.0
m. Digitized images were processed with Adobe Photoshop.
Phenotypic Screening of Cataracts—Phenotypic screening
was performed via slit lamp examination as described (18).
Mouse pupils were dilated by 1% atropine, and 15 min later
lenses were examined with a slit lamp. Observed opacities were
quantified using the Lens Opacities Classification System, ver-
sion II (18–20). For ex vivophenotyping, eyeswere dissected for
lens phenotyping by ex vivo dark field photomicroscopy as
described previously (21, 22). For measurement of glucose lev-
els, mice were fasted for 8 h. Glucose was measured in blood
from the tail vein using the Elite system (Bayer) glucometer as
described by the manufacturer. The data were analyzed with
analysis of variance (p 0.05 for limit).
RESULTS
Generation of Sep15 KO Mice—Sep15 KO mice were gener-
ated by homologous recombination. The KO construct was
designed to exchange exon 2with the selectionmarker followed
by a transcription termination signal (Fig. 1, A and B). Geno-
types of mice were confirmed by PCR analysis. However, sub-
sequent RT-PCR analysis showed a signal of Sep15 mRNA in
Sep15 KO tissues. To determine the organization of this
mRNA, we used primer pairs for various parts of the Sep15
mRNA (Fig. 1C). Amplification with primers specific for the
first and third exons gave fragments of different sizes in WT
and Sep15 KOmice, whereas the use of primers downstream of
exon 3 showed fragments of similar size. Further sequencing of
the fragment amplified with primers specific for exons 1 and 5
revealed that the truncated Sep15 KO mRNA lacked exon 2.
However, because the reading frame was preserved and the
shortenedmRNA formhad both an in-frameUGA codon and a
SECIS element in the 3 UTR, the possibility that the mutant
mRNA supported Sec insertion and therefore selenoprotein
synthesis had to be considered. To test for possible expression
of the shortened protein product in Sep15 KO mice, we pre-
paredMEFs fromWT and Sep15 KOmice and subjected them
to metabolic labeling with 75Se (Fig. 1D). Selenoprotein pat-
terns were similar inWT and Sep15 KOMEFs, with the excep-
tion of a 14-kDa band that wasmissing in Sep15KOMEFs. This
band corresponded to the migration property of Sep15 follow-
ing removal of the N-terminal signal peptide. To verify that the
FIGURE 1.Preparation of Sep15KOmice. A, structure of themouse Sep15 gene. B, structure of the KO allele. Coding regions are shown in light gray, andDNA
flanking regions used for homologous recombination are shown in dark gray. The second exon was replaced with the Neo gene containing a transcription
termination signal. C, RT-PCR analysis of Sep15 mRNA in WT and Sep15 KOmice with primers for the indicated regions of Sep15. The aldolase gene was used
as a control.D, analysis of Sep15 expression inMEFs derived fromWT and Sep15 KOmice. Cells were labeled with 75Se followed by immunoprecipitation with
antibodies specific for Sep15. The two left lanes show labeledMEFs. Immunoprecipitated (i.p.) and flow-through (flow) fractions are shown for eachMEF line in
the right lanes. The arrow on the right indicates migration of Sep15.
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14-kDa band was Sep15, we carried out immunoprecipitation
with Sep15-specific antibodies. This analysis precipitated a
14-kDa protein in WT MEFs but not in Sep15 KO MEFs (Fig.
1D). In addition, we did not detect any selenoprotein bands
migrating lower than 14 kDa in eitherWTor Sep15KOsamples
subjected to immunoprecipitation. These data suggest that
Sep15 KO mice express neither Sep15 nor its shortened form
lacking sequences encoded by exon 2.
Characterization of the Truncated Sep152Form—Because
Sep15 KO mice synthesized a shortened mRNA form, we fur-
ther examined the possibility that it could code for a protein
fragment. The predicted size of Sep15 selenoprotein lacking the
region encoded by exon 2 (further designated Sep152) is 107
amino acids (11.6 kDa) (Fig. 2, A and B). Transfection of the
Sep152 construct into HEK293 cells did not reveal a band of
the expected size when cells were labeled with 75Se (Fig. 2C).
We also tested the possibility that Sep152 was secreted by cells
because it lacked the domain that retained the protein in the ER
due to interaction with UGT. To exclude this possibility, we
prepared constructs for Cys mutants (i.e. Cys replacing Sec) of
Sep152 and Sep15 fused with GFP. HEK293 cells transfected
with these constructs showed Sep152-GFP and Sep15-GFP
bands, and these protein formswere absent in themedium (Fig.
2D). We also transfected NIH 3T3 cells with the same con-
structs and examined localization of Sep15 protein forms (Fig.
2E). Full-length Sep15-GFP colocalized with the ER tracker,
whereas Sep152-GFP showed a different localization pattern
wherein the protein seemed to be in granules (it did not corre-
spond to mitochondria or lysosomes). Thus, Sep152 was not
expressed in transfectedmammalian cells on the basis ofWest-
ern blot analysis data, extremely sensitive 75Se labeling of cell
lysates, and immunoprecipitation of Sep15 from 75Se-labeled
cells. When Sep152 was fused to a large globular protein (i.e.
GFP) and, in addition, had its Sec replaced with Cys (Sec inser-
tion is very slow, and replacing this residuewithCys is amethod
used to dramatically increase protein expression), the protein
could be expressed, but it changed localization. We conclude
from the above observations that Sep15KOcells lack functional
Sep15.
Absence of Sep15 Does Not Affect Expression of Other
Selenoproteins—Selenoprotein expression depends on avail-
ability of dietary Se (23, 24). In addition, removal of one seleno-
protein may affect expression of other selenoproteins, e.g.
because of increased availability of Sec-tRNA or by influencing
redox homeostasis. To examine this possibility, WT and
heterozygous and homozygous Sep15 KO mice were metabol-
ically labeled with 75Se (supplemental Fig. S1). However,
expression of other selenoproteins was unchanged.
Oxidative Stress in Sep15 KO Mice—We examined parame-
ters of oxidative stress in livers of WT and Sep15 KO mice.
Sep15 KO livers showed increased levels of malondialdehyde
(p  0.0001) and protein carbonyls (p  0.0001), whereas
amounts of total thiols and protein thiols were found to be
decreased compared with controls (p 0.05) (Fig. 3). The data
show increased lipid and protein oxidation and suggest mild
oxidative stress in Sep15 KO livers.
Analysis of Sep15KOMice for Prostate and Brain Pathologies—
Sep15 is expressed at elevated levels in prostate, liver, kidney,
FIGURE 2. Characterization of a shortened Sep15 form. A, amino acid sequence and predicted size of Sep152. B, schematic representation of domain
organization of Sep15 and its correspondence to gene structure. C, Sep15 and Sep152 were expressed in HEK293 cells followed by labeling of cells with 75Se.
Expression of proteins was compared with the selenoprotein expression profile in MEFs derived fromWT and Sep15 KOmice. D, Western blot analysis of Cys
mutants of Sep15-EGFP and Sep152-EGFP expressed in NIH 3T3 cells. Protein expressionwas analyzed in cell extracts and concentratedmedia. E, localization
of Sep15 and Sep152. Colocalization of Sep15 forms (green) and the ER marker (blue) are shown.
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testis, and brain (25). At the same time, Sep15 expression is
decreased in malignant prostate cell lines and in hepatocarci-
noma.We examined Sep15 KOmice for phenotypes associated
with prostate and brain. Prostate was examined in 1.5 year-old
males (n  13) (supplemental Fig. S2A). No signs of neoplasia
were observed. PSA is a plasma protein whose expression is
increased during prostate pathologies, such as inflammation
and malignant transformation. No differences in PSA levels
were observed in serum samples of WT and Sep15 KO mice
(supplemental Fig. S2B).
Selenoprotein deficiency is also known to be associated with
neuronal pathology (24). For example, mice lacking SelP show
seizures and ataxia and die before weaning when fed a Se-defi-
cient diet (26). Comparative analysis of gene expression data in
the Allen Brain Atlas revealed expression of all selenoproteins
and selenocysteine incorporative machinery in the brain,
including high expression of Sep15 (27). In addition, disruption
of neuronal expression of selenoproteins led to neurological
symptoms and neurodegeneration (28, 29). Similar symptoms
were observed in glutathione peroxidase 4 (GPx4)KOmice (30)
and in TrspAE/AE mice expressing hypomorphic tRNA(Ser)Sec
(28). Sep15 expression is high inAmmon’s horn and the dentate
gyrus of the hippocampus and in Purkinje cells of the cerebellar
cortex (27).We analyzed brains of Sep15KOmice (supplemen-
tal Fig. S2). The hippocampal and cortex areas of Sep15 KO
mice showed no signs of astrogliosis, and its levels of glial fibril-
lary acidic protein and parvalbumin were similar to those in
WT mice. Thus, Sep15 deficiency did not lead to the loss of
parvalbumin-positive interneurons observed in mouse models
with a general deficiency in selenoprotein expression. Analysis
of cerebellar morphology of Sep15 KOmice also did not reveal
abnormalities. Thus, Sep15 deficiency does not lead to sponta-
neous neurodegeneration, consistent with an apparent lack of
behavioral phenotypes.
Sep15 Deficiency Does Not Influence SelP Secretion—As a
UGT-binding partner, Sep15 may be involved in protein fold-
ing and secretion. Sep15 is also regulated by the unfolded pro-
tein response (UPR). SelP is a major plasma selenoprotein syn-
thesized in the liver and transporting Se to other organs. SelP
maturation, intracellular transport, and secretion occur
through the common ER-Golgi pathway in the liver (31). We
examined the possibility that Sep15 KO affects SelP secretion.
Hepatocytes from WT and Sep15 KO mice were isolated and
metabolically labeled with 75Se. The cells were also treatedwith
compounds that compromise function of the ER-Golgi path-
way (supplemental Fig. S3). This treatment did not affect the
viability of cells (data not shown). Treatment of hepatocytes
with brefeldin A is known to abrogate SelP secretion, which is
what we observed in both WT and Sep15 KO hepatocytes,
whereas treatment with tunicamycin and monensin caused
accumulation of intracellular non-glycosylated or partially gly-
cosylated SelP forms. As expected, treatment with this com-
pound induced expression of BiP in both WT and Sep15 KO
hepatocytes.
Sep15DeficiencyDoesNot Lead toActivation of theUPR—To
further assess the function of Sep15, WT and Sep15 KO mice
were injected intraperitoneally with 1g/g bodyweight tunica-
mycin or vehicle and sacrificed 72 h after injection. This treat-
ment induced both BiP and Sep15 expression inWTmice (Fig.
4), consistent with previous data in cell culture (9). BiP was
elevated similarly inWT and Sep15 KOmice, so the absence of
Sep15 did not augment the UPR.
Sep15 mRNA Expression Is Progressively Lens-enriched dur-
ing Mouse Development—Because our data suggested that
Sep15 may play a role in the quality control of protein folding,
we hypothesized that deficiency in this protein may lead to
proteinmisfolding or aggregation. A prominent human disease
associated with altered protein folding is cataract formation,
FIGURE 3. Oxidative stress in Sep15 KO mice. Levels of malondialdehyde, protein carbonyls, total thiols, and protein thiols in livers of WT (white bars) and
Sep15 KO (black bars) mice are shown as mean S.D. *, p 0.001.
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with opacities caused by aggregation of lens structural proteins
such as -crystallins. It has been proposed that genes that are
expressed in a lens-enriched manner in the developing mouse
lens may have a functional role in the development and main-
tenance of lens transparency and, therefore,may represent can-
didate genes for cataract formation (32). In this approach, lens
enrichment of a candidate gene is scored against its expression
in whole embryonic tissues at various stages in development3
This approach has been successful in identifying cataract loci
(33). Therefore, we investigated whether Sep15 mRNA was
enriched in the lens during stages of lens invagination (E10.5)
through primary fiber cell differentiation (E12.5). We found
expression of Sep15 mRNA to be progressively enriched at
E12.5 (Fig. 5). To gain insights into Sep15 protein expression in
the lens, we performed immunofluorescence experiments
using Sep15 antibodies and analyzed lens sections at various
stages of mouse embryonic development (Fig. 5B and supple-
mental Fig. S4). Our data indicate that Sep15 protein is
expressed in the anterior epithelium of the lens. In addition,
conforming to the progressive enrichment of Sep15 transcripts
in the lens, Sep15 protein expression was also found to be pro-
gressively enriched during lens development. For example,
Sep15 expression in the lens anterior epithelium was found to
be significantly higher in the E18.5 when compared with the
E13.5 embryos. Together, the expression data are consistent
with an important role of Sep15 during lens development.
Development of Cataract in Sep15 KO Mice—To directly
assess cataract formation in Sep15 KOmice, we carried out slit
lamp examination for cataract scoring, which revealed lens
opacity in bothmale (n 10) and female (n 7) Sep15KOmice
(Fig. 6A). Observed opacities were quantified using the Lens
Opacities Classification System, version II. Nuclear changes
were classified by scoring the degree of opalescence. In our
experiment, a clear lens was assigned a grade of 0 and a fully
opaque lens a grade of 5. The opacity grade increased with age,
on the basis of the comparison of 1.5 and 6-month old females
(n 12). Fundus camera examination was also conducted, and
representative images are shown in Fig. 6B. A group of Sep15
KO mice was examined by slit lamp followed with ex vivo phe-
notyping, including lens dissection followed by microscopy
analyses. In this experiment, we used 2.5-month oldmales (n
3) and females (n  3) as well as 10-month-old males (n  4)
and females (n  3). Both lenses of each KO mouse showed
nuclear opacity that increased in size with age. Sep15 KOmice
predominantly developed nuclear cataracts. Representative
images of the lenses dissected from 2-month and 10-month
Sep15 KO and control mice are shown in Fig. 6, C–H, and sup-
plemental Fig. S5. Although some of the 10-month-old control
mice developed age-related punctate opacity (Fig. 6H), cataract
formation in Sep15 KO mice was more prominent and
occurred in all mice. Moreover, all examined 2-month-old
Sep15 KO mice had cataracts, whereas cataract formation was
not observed in 2-month-old controls. To further characterize
cataracts, we performed a histological analysis of lenses derived
from 3-month-old Sep15 KO and control mice. Lenses from
Sep15 KO mice demonstrated extensive vacuolization and
aberrant structure of fiber cells evident in the lens nuclear
region (supplemental Fig. S6). Together, the expression data
suggest an important role for Sep 15 in development andmain-
tenance of lens transparency.
DISCUSSION
Sep15 is an ER-resident protein implicated in the calnexin-
dependent quality control cycle. Our previous studies showed
that Sep15 forms a 1:1 complex with UGT, a protein that rec-
ognizes improperly folded or partially unfolded glycoproteins
and subjects them to the calnexin cycle. In addition to the Cys-
3 S. A. Lachke, G. V. Kryukov, J. W. Ho, D. J. O’Connell, S. E. Choe, A. Aboukhalil,
M. L. Bulyk, P. Park, S. R. Sunyaev, and R. L. Maas,manuscript in preparation.
FIGURE4.Sep15deficiencydoesnot lead toactivationof theUPR.WTand
Sep15 KO mice were injected intraperitoneally with tunicamycin (Tun) (1
g/g body weight) or vehicle. 72 h after injection, mice were euthanized,
livers extracted, andprotein lysates from livers probedby immunoblot assays
with polyclonal antibodies specific for Sep15 and BiP or monoclonal -actin
antibody as a loading control.
FIGURE 5. Enrichment of Sep15mRNAduring lens development. A, Sep15
mRNAexpressionwas analyzedat the indicated stagesof embryogenesis and
comparedwith thewholebodySep15mRNAexpression. *,p0.05.Over 150
lenses (representing each embryonic stage) from E10.5-, E11.5-, and E12.5-
stage mouse embryos were pooled for each biological replicate, and the
microarray was performed in triplicate. The graph is based on the expression
values, in the lens or whole body samples, of normalized fluorescent signal
intensities for the probe dataset specific to the Sep15 gene. B, immunofluo-
rescent stainingof lens at E13.3 andE18.5.AEL, anterior epitheliumof the lens;
FC, fiber cells. Sep15 staining is shown in red, and DAPI staining is shown in
blue. Theasterisks indicate a significant increase in Sep15 signal in theanterior
epithelium of the lens.
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rich UGT-binding domain, Sep15 has a thioredoxin-like
domain containing a redox active CXU (Cys and Sec separated
by another residue) motif, suggesting a thiol oxidoreductase
function for this protein. Sep15 is also differentially regulated
by ER stress. Adaptive ER stress caused by tunicamycin or
brefeldin A treatments induces Sep15 expression, whereas
acute stress caused by treatments with disulfide-reducing DTT
or thapsigargin, a compound that disrupts calcium flux from
the ER, leads to a rapid proteasomal degradation of Sep15 (9).
However, the specific function of Sep15 in these processes is
not known. Sep15 is expressed at elevated levels in secretory
organs such as prostate, liver, kidney, testis, and brain. At the
same time, Sep15 expression is decreased in prostate cancer
cells and in hepatocarcinoma. Stable Sep15 knockdown was
also found to make cells more susceptible to oxidative stress.
In this study, we generated and characterized Sep15KOmice
that were viable and fertile and with no obvious phenotypes
during development and growth. These mice were obtained by
deleting exon 2 coding for the UGT-binding domain of Sep15.
Although the mRNA for a shortened Sep15 form was synthe-
sized, the corresponding protein could not be detected under
any conditions tested. Moreover, even when this protein form
was forced into expression in cell culture by fusion with GFP
and replacement of Sec with Cys, it had an abnormal localiza-
tion. Therefore, Sep15 KO mice lacked functional Sep15.
Initial characterization of Sep15 KO mice revealed no phe-
notypes with regard to expression of other selenoproteins, sus-
ceptibility to treatments that induce ER stress, or protein secre-
tion. Strong interaction between Sep15 with UGT implied the
role of Sep15 in the quality control of glycoprotein folding.
Thus, we analyzed the effect of Sep15 deficiency on secretion of
plasma glycoprotein SelP. However, no differences were found
between WT and Sep15 KO hepatocytes subjected or not sub-
jected to ER stress. Apparently, SelP is not a target of Sep15.
Previous experiments in cell culture also suggested the involve-
ment of Sep15 in theUPR. Therefore, we examined the levels of
BiP (amarker of UPR) inWT and Sep15KOhepatocytes. Tuni-
camycin treatment led to a robust increase in BiP expression in
Sep15 KO hepatocytes. However, this protein was induced to a
similar level in WT and Sep15 KO mice.
FIGURE6.Developmentof cataracts inSep15KOmice.A, quantificationof slit lampexaminationof control andSep15KOmice.Opacitywasquantifiedusing
the Lens Opacities Classification System, version II. The scale was from a completely clear (grade 0) to a fully opaque (grade 5) lens. L, left; R, right. B, represent-
ative images of opacities in Sep15 KO mice using a fundus camera. Six-month-old WT and Sep15 KO females were used. L, left; R, right. C–H, representative
cataracts in Sep15 KOmice. Each panel shows lenses from the same animal. The left panels represent in vivo slit lamp examination, and the right panels show
dark field analyses of the same lens examined in vitro. C andD, representative lenses from 2-month-old Sep15 KO females. Nuclear opacity is shownwith a red
arrow. E, 2-month-oldWT female (control) showing no nuclear opacity. F and G, 10-month-old Sep15 KO females. Nuclear opacity is shownwith red arrows. H,
10-month-old WT female that developed age-related punctate opacity.
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Although the observed phenotypes of Sep15 KO mice were
mild, we reasoned that because Sep15 is elevated by the UPR,
Sep15 deficiency might modulate development of certain ER
stress-associated diseases. One such disease is cataract forma-
tion resulting from improper protein folding and posttransla-
tional modifications, leading to decreased lens transparency. It
has been proposed that lens-enriched genes may represent
promising targets associated with cataract formation. Recently,
deficiency of a gene with a highly lens-enriched expression pat-
tern was found to cause congenital cataracts in humans, mice,
and chickens (29, 30). We found that Sep15 mRNA was pro-
gressively enriched in three critical stages of mouse lens devel-
opment. In addition, transcripts for several proteins function-
ally linked to Sep15 were found to be enriched in the lens (e.g.
UGT1, calreticulin), whereas others (e.g. UGT2, calnexin,
ERp57, and SelM), although not enriched, were expressed in
the lens. This provides further support that Sep15 function is
important in the lens.
Further analysis revealed that nearly every Sep15 KOmouse
developed mild nuclear cataracts, some as early as 1.5 months
of age. One of the factors thatmay influence cataract formation
is glucose imbalance.We analyzed glucose levels in fastedmice,
but they were comparable with those in WT controls (supple-
mental Fig. S7). Cataracts may also result from increased pro-
tein oxidation and aggregation. Indeed, we found that Sep15
KOmice showed increased levels of both lipid and protein oxi-
dation. To further examine this possibility, we analyzed the
ratio of reduced to oxidized glutathione and levels of thiols in
lenses. However, these parameters were similar in Sep15 KO
and WT lenses (supplemental Fig. S7, B and C). Therefore, it
remains to be determinedwhether Sep15KO induced cataracts
are directly associated with general oxidative stress. Another
explanation for cataract formation is the improper folding or
disulfide status of Sep15 targets. For example, similar symp-
toms were described previously in mice lacking connexin 46
(34, 35). Connexins are a family of gap junction proteins
whose mutations are associated with cataract development
in human subjects (36, 37). In the case of Sep15 KO cataracts,
further studies are needed to determine the precise function
of Sep15 in protein folding, but interaction of this selenopro-
tein with the protein folding sensor is consistent with the
role of protein misfolding in Sep15-dependent cataract
development.
Overall, this study shows that the absence of Sep15 does not
affect viability and does not lead to obvious phenotypes inmice.
To better understand Sep15 function and the role of this sel-
enoprotein in glycoprotein folding, it would be important to
identify the subset of Sep15 targets and examine their post-
translational modifications in WT and Sep15 KO mice. Cata-
racts are themajor cause of blindness in theworld. Several types
of cataracts are associatedwith excessive ER stress and theUPR
(38, 39). However, little is known about the link between defec-
tive protein secretion pathways and cataract formation. Future
experiments in this direction may lead to a better understand-
ing of the association between abnormal glycoprotein folding/
modification and human disease.
REFERENCES
1. Battin, E. E., and Brumaghim, J. L. (2009) Cell Biochem. Biophys. 55, 1–23
2. Hoffmann, P. R., and Berry, M. J. (2008) Mol. Nutr. Food Res. 52,
1273–1280
3. Jackson, M. I., and Combs, G. F., Jr. (2008) Curr. Opin. Clin. Nutr. Metab.
Care 11, 718–726
4. Papp, L. V., Lu, J., Holmgren, A., and Khanna, K. K. (2007)Antioxid. Redox
Signal. 9, 775–806
5. Lobanov, A. V., Hatfield, D. L., and Gladyshev, V. N. (2009) Biochim.
Biophys. Acta 1790, 1424–1428
6. Gladyshev, V. N., Jeang, K. T., Wootton, J. C., and Hatfield, D. L. (1998)
J. Biol. Chem. 273, 8910–8915
7. Ferguson, A. D., Labunskyy, V. M., Fomenko, D. E., Arac¸, D., Chelliah, Y.,
Amezcua, C. A., Rizo, J., Gladyshev, V. N., and Deisenhofer, J. (2006)
J. Biol. Chem. 281, 3536–3543
8. Korotkov, K. V., Kumaraswamy, E., Zhou, Y., Hatfield, D. L., and Glady-
shev, V. N. (2001) J. Biol. Chem. 276, 15330–15336
9. Labunskyy, V. M., Yoo, M. H., Hatfield, D. L., and Gladyshev, V. N. (2009)
Biochemistry 48, 8458–8465
10. Hu, Y. J., Korotkov, K. V.,Mehta, R., Hatfield, D. L., Rotimi, C. N., Luke, A.,
Prewitt, T. E., Cooper, R. S., Stock, W., Vokes, E. E., Dolan, M. E., Glady-
shev, V. N., and Diamond, A. M. (2001) Cancer Res. 61, 2307–2310
11. Kumaraswamy, E., Malykh, A., Korotkov, K. V., Kozyavkin, S., Hu, Y.,
Kwon, S. Y.,Moustafa,M. E., Carlson, B. A., Berry,M. J., Lee, B. J., Hatfield,
D. L., Diamond, A. M., and Gladyshev, V. N. (2000) J. Biol. Chem. 275,
35540–35547
12. Kumaraswamy, E., Korotkov, K. V., Diamond,A.M., Gladyshev, V.N., and
Hatfield, D. L. (2002)Methods Enzymol. 347, 187–197
13. Irons, R., Tsuji, P. A., Carlson, B. A., Ouyang, P., Yoo, M. H., Xu, X. M.,
Hatfield, D. L., Gladyshev, V. N., and Davis, C. D. (2010)Cancer. Prev. Res.
(Phila.) 3, 630–639
14. Hatfield, D. L., Yoo, M. H., Carlson, B. A., and Gladyshev, V. N. (2009)
Biochim. Biophys. Acta 1790, 1541–1545
15. Bahjat, F. R., Dharnidharka, V. R., Fukuzuka, K.,Morel, L., Crawford, J.M.,
Clare-Salzler, M. J., and Moldawer, L. L. (2000) J. Immunol. 165,
6559–6567
16. Gohla, A., Klement, K., Piekorz, R. P., Pexa, K., vom Dahl, S., Spicher, K.,
Dreval, V., Ha¨ussinger, D., Birnbaumer, L., and Nu¨rnberg, B. (2007) Proc.
Natl. Acad. Sci. U.S.A. 104, 3003–3008
17. Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T.,
Remotti, H., Stevens, J. L., and Ron, D. (1998) Genes Dev. 12, 982–995
18. Wang, K., Cheng, C., Li, L., Liu, H., Huang, Q., Xia, C. H., Yao, K., Sun, P.,
Horwitz, J., and Gong, X. (2007) Invest. Ophthalmol. Vis. Sci. 48,
3719–3728
19. Taylor, H. R., Lee, J. A., Wang, F., and Mun˜oz, B. (1991) Invest. Ophthal-
mol. Vis. Sci. 32, 529–532
20. Leske, M. C., Chylack, L. T., Jr, Sperduto, R., Khu, P., Wu, S. Y., and
McCarthy, D. (1988) Arch. Ophthalmol. 106, 327–329
21. Goldstein, L. E., Muffat, J. A., Cherny, R. A., Moir, R. D., Ericsson, M. H.,
Huang, X., Mavros, C., Coccia, J. A., Faget, K. Y., Fitch, K. A., Masters,
C. L., Tanzi, R. E., Chylack, L. T., Jr., and Bush, A. I. (2003) Lancet 361,
1258–1265
22. Moncaster, J. A., Pineda, R.,Moir, R. D., Lu, S., Burton,M. A., Ghosh, J. G.,
Ericsson, M., Soscia, S. J., Mocofanescu, A., Folkerth, R. D., Robb, R. M.,
Kuszak, J. R., Clark, J. I., Tanzi, R. E., Hunter, D. G., and Goldstein, L. E.
(2010) PLoS ONE 5, e10659
23. Schomburg, L., and Schweizer, U. (2009) Biochim. Biophys. Acta 1790,
1453–1462
24. Schweizer, U., Bra¨uer, A. U., Ko¨hrle, J., Nitsch, R., and Savaskan, N. E.
(2004) Brain Res. Brain Res. Rev. 45, 164–178
25. Labunskyy, V.M., Hatfield, D. L., andGladyshev, V. N. (2007) IUBMB Life
59, 1–5
26. Schweizer, U., Michaelis, M., Ko¨hrle, J., and Schomburg, L. (2004)
Biochem. J. 378, 21–26
27. Zhang, Y., Zhou, Y., Schweizer, U., Savaskan, N. E., Hua, D., Kipnis, J.,
Hatfield, D. L., and Gladyshev, V. N. (2008) J. Biol. Chem. 283, 2427–2438
28. Carlson, B. A., Schweizer, U., Perella, C., Shrimali, R. K., Feigenbaum, L.,
Characterization of Sep15 KnockoutMice
SEPTEMBER 23, 2011•VOLUME 286•NUMBER 38 JOURNAL OF BIOLOGICAL CHEMISTRY 33211
  
Shen, L., Speransky, S., Floss, T., Jeong, S. J., Watts, J., Hoffmann, V.,
Combs, G. F., Gladyshev, V. N., and Hatfield, D. L. (2009) Biochem. J. 418,
61–71
29. Wirth, E. K., Conrad, M., Winterer, J., Wozny, C., Carlson, B. A., Roth, S.,
Schmitz, D., Bornkamm, G. W., Coppola, V., Tessarollo, L., Schomburg,
L., Ko¨hrle, J., Hatfield, D. L., and Schweizer, U. (2010) FASEB J. 24,
844–852
30. Seiler, A., Schneider, M., Fo¨rster, H., Roth, S., Wirth, E. K., Culmsee, C.,
Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., Bornkamm, G. W.,
Schweizer, U., and Conrad, M. (2008) Cell Metab. 8, 237–248
31. Steinbrenner, H., Alili, L., Stuhlmann, D., Sies, H., and Brenneisen, P.
(2007) Biol. Chem. 388, 1043–1051
32. Lachke, S. A., andMaas, R. L. (2010)Wiley Interdiscip. Rev. Syst. Biol.Med.
2, 305–323
33. Lachke, S. A., Alkuraya, F. S., Kneeland, S. C., Ohn, T., Aboukhalil, A.,
Howell, G. R., Saadi, I., Cavallesco, R., Yue, Y., Tsai, A. C., Nair, K. S.,
Cosma, M. I., Smith, R. S., Hodges, E., Alfadhli, S. M., Al-Hajeri, A.,
Shamseldin, H. E., Behbehani, A., Hannon, G. J., Bulyk, M. L., Drack,
A. V., Anderson, P. J., John, S. W., and Maas, R. L. (2011) Science 331,
1571–1576
34. Gong, X., Agopian, K., Kumar, N. M., and Gilula, N. B. (1999)Dev. Genet.
24, 27–32
35. Graw, J. (2009) J. Genet. 88, 469–486
36. Pfenniger, A.,Wohlwend, A., andKwak, B. R. (2011)Eur. J. Clin. Invest. 41,
103–116
37. Santhiya, S. T., Kumar, G. S., Sudhakar, P., Gupta, N., Klopp, N., Illig, T.,
So¨ker, T., Groth,M., Platzer,M., Gopinath, P.M., andGraw, J. (2010)Mol.
Vis. 16, 1837–1847
38. Ikesugi, K., Yamamoto, R., Mulhern, M. L., and Shinohara, T. (2006) Exp.
Eye Res. 83, 508–516
39. Shinohara, T., Ikesugi, K., andMulhern, M. L. (2006)Med. Hypotheses 66,
365–370
Characterization of Sep15 KnockoutMice
33212 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 38•SEPTEMBER 23, 2011
 
Supplementary information 
 
 
Figure S1. Metabolic labeling of WT and Sep15
 
KO
 
mice with 
75
Se. WT (Sep15
+/+
), and heterozygous 
(Sep15
+/-
) and homozygous (Sep15
-/-
) Sep15 KO
 
mice were each injected with 40 µCi of 
75
Se. 
Selenoprotein expression was analyzed in indicated organs by SDS-PAGE followed by PhosphorImager.  
  
 Figure S2. Analyis of prostate and brain pathologies in Sep15 KO
 
mice. (A) H&E staining of prostate 
sections in WT and Sep15 KO mice. (B) Western blot analysis of PSA in serum of WT and Sep15 KO 
mice (upper panel). Coomassie Blue staining as a protein loading control (loading). (C) Analysis of brain 
sections: Nissl, GFAP and parvalbumin staining of the hippocampal area of WT and Sep15 KO
 
mice. 
Also shown are immunohistochemistry of cerebral cortex area with GFAP antibodies and Nissl staining 
of cerebellum. 
  
 Figure S3. Sep15 deficiency does not affect SelP secretion. Hepatocytes were isolated from WT and 
Sep15 KO mice and metabolically labeled with 
75
Se. PhosphorImager analysis of cellular extracts (left 
panel) and concentrated media (right panel). Membranes were further analyzed with BiP and β-actin 
(lower left panels) and SelP (lower right panel) antibodies. 
  
  
Figure S4. Sep15 expression in the lens during development. Mouse embryonic coronal section at 
E18.5 was stained with Sep15 antibody (Sep15) or with secondary antibody-only as a negative control 
(Control). AEL, anterior epithelium of the lens. FC, fiber cells. Sep15 staining is in red, and DAPI in 
blue.  
 
  
  
Figure S5. Development of cataracts in Sep15 KO mice. (A) Whole eyeball dissected from a 10-month 
old Sep15 KO female, which had anterior nuclear cataract (white arrow).  Lenses of WT mice were clear, 
while opacity was evident in Sep15 KO mice. (B) Lenses dissected from a 10-month old Sep15 KO and 
WT (control) male mice. (C) High magnification images from boxed region in (B). Arrows in B and C 
point to the detected abnormalities. Absence of abnormalities (asterisk) in the control lenses. 
  
  
Figure S6. Histological analysis of control and Sep15 KO mice. H&E staining of lens sections from 3 
month old WT and Sep15 KO mice is shown.  At 40x magnification, abnormalities in the central region 
of the lens can be detected in Sep15 KO mice, but not in control. White arrow indicates the regular 
pattern of lens fiber cells in control lens, and asterisk shows disruption of this structure in the Sep15 KO 
lens.  
 
 
  
  
Figure S7. Comparison of glucose levels and oxidative stress parameters in the lenses of WT and 
Sep15 KO mice. (A) WT and Sep15 KO mice were fasted overnight and blood was analyzed for glucose 
levels (n=9 for WT and 12 for Sep15 KO mice). (B) Lenses were extracted from WT and Sep15 KO 
mice. Protein extracts were analyzed for (B) ratio of oxidized to reduced glutathione and (C) total thiol 
levels. In each group, n=3.  
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